DocDollars

Valneva Austria GMBH

Austria · Reporting entity ID 100000010526

Total reported 2019–2025
$50.5M
#174 of 2,960 reporting companies — 0.1% of all reported industry payments
$130K in general payments across 69 records, plus $50.4M in research funding across 3,447 records.

How it breaks down

General payments $130,204
Research funding $50,419,573

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Valneva Austria GMBH reported $50.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #174 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 69 general payment records and 3,447 research records were filed.

Common questions about Valneva Austria GMBH

How much has Valneva Austria GMBH paid US doctors?

Valneva Austria GMBH reported $50,549,777 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $130,204 in general payments, $50,419,573 in research funding.

How does Valneva Austria GMBH rank among drug and device companies?

It ranks #174 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Valneva Austria GMBH mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.